Recombinant factor VIIa: unregulated continuous use in patients with bleeding and coagulopathy does not alter mortality and outcome.
about
Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital recordsOff-label recombinant factor VIIa use and thrombosis in children: a multi-center cohort study.Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
P2860
Recombinant factor VIIa: unregulated continuous use in patients with bleeding and coagulopathy does not alter mortality and outcome.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Recombinant factor VIIa: unreg ...... t alter mortality and outcome.
@ast
Recombinant factor VIIa: unreg ...... t alter mortality and outcome.
@en
type
label
Recombinant factor VIIa: unreg ...... t alter mortality and outcome.
@ast
Recombinant factor VIIa: unreg ...... t alter mortality and outcome.
@en
prefLabel
Recombinant factor VIIa: unreg ...... t alter mortality and outcome.
@ast
Recombinant factor VIIa: unreg ...... t alter mortality and outcome.
@en
P2093
P2860
P1476
Recombinant factor VIIa: unreg ...... t alter mortality and outcome.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2257.2006.00815.X
P577
2006-10-01T00:00:00Z